Mitchell D. Nambu
Impact in
- Hepatology top 5%
- Liver physiology and pathology
- Oncology top 10%
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Signaling Pathways in Disease 1
- Biochemical and Structural Characterization 1
- PI3K/AKT/mTOR signaling in cancer 1
- Protein Kinase Regulation and GTPase Signaling 1
- Phosphodiesterase function and regulation 1
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Helen Y. Zou (2 shared papers)Qiuhua Li (2 shared papers)Shinji Yamazaki (2 shared papers)Gerrit Los (1 shared paper)Gordon Alton (1 shared paper)Barbara Mroczkowski (1 shared paper)Maria E. Arango (1 shared paper)Steven L. Bender (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)Cancer Research (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Mitchell D. Nambu
3 papers receiving 621 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Hepatology 169
- Oncology 286
- Pulmonary and Respiratory Medicine 271
- Pathology and Forensic Medicine 115
- Molecular Biology 351
Countries citing papers authored by Mitchell D. Nambu
This map shows the geographic impact of Mitchell D. Nambu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell D. Nambu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell D. Nambu more than expected).
Fields of papers citing papers by Mitchell D. Nambu
This network shows the impact of papers produced by Mitchell D. Nambu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell D. Nambu. The network helps show where Mitchell D. Nambu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell D. Nambu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms Hit paper breakdown → | 2007 | 593 |
| 2 | 2013 | 33 | |
| 3 | 2017 | 22 |
About Mitchell D. Nambu
Mitchell D. Nambu is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Microbiology, Hepatology and Infectious Diseases, having authored 3 papers that have together received 648 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (2 papers), Signaling Pathways in Disease (1 paper), Biochemical and Structural Characterization (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Phosphodiesterase function and regulation (1 paper), Antimicrobial Peptides and Activities (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Hepatology (169 citations), Oncology (286 citations), Pulmonary and Respiratory Medicine (271 citations), Pathology and Forensic Medicine (115 citations) and Molecular Biology (351 citations). Mitchell D. Nambu has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Helen Y. Zou, Qiuhua Li, Shinji Yamazaki, Gerrit Los, Gordon Alton, Barbara Mroczkowski, Maria E. Arango, Steven L. Bender, James G. Christensen and Jingrong Jean Cui. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.